{"filing":{"accession_number":"0001493152-26-035666","cik":"0001855485","ticker":"CLDWW","company_name":"Calidi Biotherapeutics, Inc.","form":"8-K","filing_date":"2026-07-31","report_date":"2026-07-27","primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1855485/000149315226035666/form8-k.htm"},"events":[{"id":22468,"run_id":20324,"accession_number":"0001493152-26-035666","anchor_item_number":null,"event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.85,"summary":"The filing discloses a 1-for-16 reverse stock split effected on July 30, 2026, explicitly stated as \"a proactive measure intended to increase the per-share trading price, support the continued listing of its Common Stock on the NYSE American and reduce the risk that its Common Stock could become subject to delisting for failure to satisfy applicable continued listing standards.\" This is a material governance action directly addressing delisting risk under continued listing standards.","company_name":"Calidi Biotherapeutics, Inc.","ticker":"CLDWW","filing_date":"2026-07-31","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":22419,"accession_number":"0001493152-26-035666","item_number":null,"item_title":null,"event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.85,"reasoning":"The filing discloses a 1-for-16 reverse stock split effected on July 30, 2026, explicitly stated as \"a proactive measure intended to increase the per-share trading price, support the continued listing of its Common Stock on the NYSE American and reduce the risk that its Common Stock could become subject to delisting for failure to satisfy applicable continued listing standards.\" This is a material governance action directly addressing delisting risk under continued listing standards.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-01T00:24:36.922267+00:00","company_name":"Calidi Biotherapeutics, Inc.","ticker":"CLDWW","filing_date":"2026-07-31"}]}